Ocugen (OCGN) Current Assets (2014 - 2026)
Ocugen (OCGN) posted Current Assets of $38.6 million for Q1 2026, up 58.39% on a QoQ basis from $24.3 million in Q4 2025, and down 12.31% year-over-year from $44.0 million in Q1 2025.
Ocugen (OCGN) Current Assets (2014 - 2026) Analysis & Trends
Ocugen's Current Assets history runs 13 years deep, the most recent figure standing at $38.6 million for Q1 2026.
- Quarterly Current Assets fell 12.31% year-over-year to $38.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $38.6 million (down 12.31% YoY) and the FY2025 annual result came in at $24.3 million, down 60.54% from the prior year.
- Current Assets was $38.6 million for Q1 2026 at Ocugen, up from $24.3 million in the prior quarter.
- Across five years, Current Assets topped out at $138.0 million in Q1 2022 and bottomed at $18.6 million in Q2 2024.
- A 5-year average of $61.9 million and a median of $44.0 million in 2025 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2022 — Current Assets soared 168.77% — and 2024, when it tumbled 74.65%.
- Ocugen's Current Assets stood at $98.5 million in 2022, then sank by 56.37% to $43.0 million in 2023, then soared by 43.54% to $61.7 million in 2024, then slumped by 60.54% to $24.3 million in 2025, then soared by 58.39% to $38.6 million in 2026.
- Business Quant data shows OCGN's Current Assets at $38.6 million in Q1 2026, $24.3 million in Q4 2025, and $37.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 289.93 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 73.04 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 6.60 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 35.73 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 11.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 18.21 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 521.86 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 8.07 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.97 Bn |
| 10 | Ocugen | 63.79 Mn | 63.79 Mn | - | 38.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.55 Mn |
| Dec 31, 2025 | 24.34 Mn |
| Sep 30, 2025 | 37.64 Mn |
| Jun 30, 2025 | 32.88 Mn |
| Mar 31, 2025 | 43.96 Mn |
| Dec 31, 2024 | 61.68 Mn |
| Sep 30, 2024 | 40.67 Mn |
| Jun 30, 2024 | 18.62 Mn |
| Mar 31, 2024 | 30.00 Mn |
| Dec 31, 2023 | 42.97 Mn |
| Sep 30, 2023 | 56.56 Mn |
| Jun 30, 2023 | 73.45 Mn |
| Mar 31, 2023 | 84.40 Mn |
| Dec 31, 2022 | 98.49 Mn |
| Sep 30, 2022 | 107.50 Mn |
| Jun 30, 2022 | 122.57 Mn |
| Mar 31, 2022 | 138.03 Mn |
| Dec 31, 2021 | 102.65 Mn |
| Sep 30, 2021 | 113.45 Mn |
| Jun 30, 2021 | 121.63 Mn |